SCHEMBL4945163

SCHEMBL4945163

C[C@@]12CCC[C@H]1[C@@H]1CCC3=CC(=O)C(O)C[C@@H]3[C@H]1CC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHBG P04278 2/20 0.48
▸ SERPINA6 P08185 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ SLC22A1 O15245 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ CYP19A1 P11511 5/20 0.44
▸ ESR1 P03372 1/20 0.43
▸ ESR2 Q92731 1/20 0.43
▸ PDK1 Q15118 1/20 0.41
▸ PDK2 Q15119 1/20 0.41
▸ PDK3 Q15120 1/20 0.41
▸ PDK4 Q16654 1/20 0.41
▸ GRIN1 Q05586 1/20 0.40
▸ GRIN2B Q13224 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ ABCB11 O95342 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9948623 0.86 CYP19A1 (0.44) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL3356889 0.85 CYP19A1 (0.44) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL6301569 0.85 CYP19A1 (0.44) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL9947828 0.83 CYP19A1 (0.42) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL8370954 0.82 CYP19A1 (0.41) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL9948721 0.82 CYP19A1 (0.41) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL6244893 0.82 SERPINA6 (0.41) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL6832273 0.81 CYP19A1 (0.65) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL3816344 0.81 SERPINA6 (0.72) SHBGSERPINA6ALDH1A1SLC22A1THRB
SCHEMBL6244949 0.81 AR (0.49) SHBGCYP19A1GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113677348-A Treatment of migraine 费林药业公司 2021-11-19 — — CN claimed
CN-107206010-B C-19 steroids to inhibit neovascularization 库拉迪斯有限公司 2021-12-21 — — CN disclosed
CN-113677348-A Treatment of migraine 费林药业公司 2021-11-19 — — CN disclosed
CN-113677348-A Treatment of migraine 费林药业公司 2021-11-19 — — CN disclosed
CN-113117089-A C-19 steroids to inhibit neovascularization 库拉迪斯有限公司 2021-07-16 — — CN disclosed
WO-2020061584-A1 TASTE-MASKED DOSAGE FORMS MSB HOLDINGS, INC. (US) 2020-03-26 — — WO disclosed
US-20080075772-A1 PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS ACCU-BREAK TECHNOLOGIES, INC. 2008-03-27 — — US disclosed
EP-1379253-A1 METHODS OF MAKING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7ALPHA,11BETA-DIMETHYL-17BETA-HYDROXYESTRA-4, 14-DIEN-3-ONE AND 17 ESTERS THEREOF THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2004-01-14 — — EP disclosed
WO-2003045398-A1 METHODS OF MAKING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7ALPHA, 11BETA-DIMETHY-17BETA-HYDROXYESTRA-4, 14-DIEN-3-ONE AND 17 ESTERS THEREOF THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2003-06-05 — — WO disclosed
EP-0113812-B1 PROCESS FOR THE PREPARATION OF 17-ALPHA-BROMOETHYNYL AND 17-ALPHA-IODOETHYNYL-17-BETA-HYDROXY STEROIDS, AND 17-ALPHA-BROMOETHYNYL AND 17-ALPHA-IODOETHYNYL-17-BETA-HYDROXY STEROIDS SCHERING AKTIENGESELLSCHAFT (DE) 1988-10-26 — — EP disclosed
Send feedback